Pylarify psma prostate imaging radiopharmaceuticals
Active Awarded Last action
- Contract number
- 36C25226N0395
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $739,788
Award facts
- Contract value 25% obligated
-
- $739,787.60 Current, with exercised options
- $2,959,150.40 Potential, with all options
- Completion date 12% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 12 issued a $2,959,150.40 delivery order to Progenics Pharmaceuticals Inc. on May 1, 2026, for PYLARIFY (piflufolastat F-18) prostate imaging radiopharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The order is firm fixed-price with no set-aside designation and extends through April 30, 2030. Place of performance is Bedford, MA. PYLARIFY is a radioactive diagnostic imaging agent used in positron emission tomography scans for detection and localization of prostate cancer in federal healthcare settings serving veterans.
Quick answers
Who was awarded contract 36C25226N0395?
36C25226N0395 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 1, 2026.
How much is contract 36C25226N0395 worth?
The government has obligated $739,788 on 36C25226N0395. Its potential value, with all options, is $2,959,150.
Is contract 36C25226N0395 an order under another contract?
Yes. 36C25226N0395 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25226N0395 competed?
The extent of competition for 36C25226N0395 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award